Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qinglingweishi versus sodium bicarbonate for urine alkalinization in primary gout with hyperuricemia
ChiCTR1800018518Phase 4Not yet recruiting
- Sponsor
- The Affiliated Hospital of Qingdao University
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of benzbromarone and sodium bicarbonate in gout and hyperuricemia (2 arms), sponsored by The Affiliated Hospital of Qingdao University. Primary endpoints: Blood uric acid value and Urine pH. Planned start Sep 2018; status: not yet recruiting.
02
Drugs
benzbromaronesodium bicarbonate
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on ChiCTR1800018518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018518.